FDA Takes Action to Curb Overuse of Antimicrobials in Livestock
Amid growing concerns about “superbugs,” regulators seek comment on use of antimicrobials in animal feed.
Time to Get Graphic with Cigarette Labels?
FDA is years behind in its statutory mandate to put graphic warnings on cigarette labels.
The Uncertain Benefits of GMO Labeling
Scholar argues that regulators will have difficulty applying cost-benefit analysis to mandatory GMO labeling.
A More Holistic Definition of “Healthy”
Regulator solicits input on a new rule defining when foods could be considered “healthy.”
Still Seeking Contraceptive Compromise After Zubik v. Burwell
Zubik v. Burwell highlights thorny issues surrounding Obamacare’s contraceptive coverage requirement.
Challenges in Measuring Regulatory Capture
Regulatory capture, neither inevitable nor a death trap for agencies, must be reduced to advance public policy goals.
We Need to Get Back to Work
Reviving our regulatory system should be a top priority for the next President.
Creating Guidance for an Invisible Threat
FDA issues new guidelines to medical device manufacturers to mitigate cybersecurity concerns.
Regulatory Agenda Offers Glimpse Into Obama Adminstration Priorities
Agenda details some of the Administration’s high priority rules for 2016.
What Constitutes “Natural” Foods?
The FDA requests information in possible first steps to regulate the term “natural” on food labels.
Reforming Medical Device Regulation
Researchers argue for reducing FDA involvement in medical device regulation.
Can Food Safety Regulations Lead to Environmental Harm?
Scholar argues that new food safety regime sacrifices environmental well-being.